{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:03:28Z","timestamp":1780117408833,"version":"3.54.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004070","name":"Khalifa University of Science, Technology and Research","doi-asserted-by":"publisher","award":["KU-INT-FSU-2025- 8474000778"],"award-info":[{"award-number":["KU-INT-FSU-2025- 8474000778"]}],"id":[{"id":"10.13039\/501100004070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12325-026-03569-5","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:00:30Z","timestamp":1775725230000},"page":"2474-2495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-omics Approaches for Biomarker Discovery of Uterine Fibroids: A Systematic Review"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6952-0520","authenticated-orcid":false,"given":"Fatimah","family":"Hussein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3865-1217","authenticated-orcid":false,"given":"Ola","family":"Elamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8778-4447","authenticated-orcid":false,"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5676-3221","authenticated-orcid":false,"given":"Mira","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"3569_CR1","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnab039","author":"Q Yang","year":"2022","unstructured":"Yang Q, Ciebiera M, Bariani MV, et al. Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment. Endocr Rev. 2022. https:\/\/doi.org\/10.1210\/endrev\/bnab039.","journal-title":"Endocr Rev"},{"key":"3569_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.43","author":"EA Stewart","year":"2016","unstructured":"Stewart EA, Laughlin-Tommaso SK, Catherino WH, Lalitkumar S, Gupta D, Vollenhoven B. Uterine fibroids. Nat Rev Dis Primers. 2016. https:\/\/doi.org\/10.1038\/nrdp.2016.43.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"3569_CR3","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1089\/jwh.2018.7076","volume":"27","author":"EE Marsh","year":"2018","unstructured":"Marsh EE, Al-Hendy A, Kappus D, Galitsky A, Stewart EA, Kerolous M. Burden, prevalence, and treatment of uterine fibroids: a survey of U.S. women. J Womens Health (Larchmt). 2018;27(11):1359\u201367. https:\/\/doi.org\/10.1089\/jwh.2018.7076.","journal-title":"J Womens Health (Larchmt)"},{"issue":"6","key":"3569_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1055\/s-0037-1607264","volume":"35","author":"A Al-Hendy","year":"2017","unstructured":"Al-Hendy A, Myers ER, Stewart E. Uterine fibroids: burden and unmet medical need. Semin Reprod Med. 2017;35(6):473\u201380. https:\/\/doi.org\/10.1055\/s-0037-1607264.","journal-title":"Semin Reprod Med"},{"key":"3569_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fgwh.2025.1581823","author":"P Mukherjee","year":"2025","unstructured":"Mukherjee P. Genetic and biomarker approaches to uterine fibroids: toward precision medicine. Front Glob Womens Health. 2025. https:\/\/doi.org\/10.3389\/fgwh.2025.1581823.","journal-title":"Front Glob Womens Health"},{"issue":"4","key":"3569_CR6","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1007\/s40615-021-01059-8","volume":"9","author":"M Orellana","year":"2022","unstructured":"Orellana M, Riggan KA, DSouza K, et al. Perceptions of ethnoracial factors in the management and treatment of uterine fibroids. J Racial Ethn Health Disparities. 2022;9(4):1184\u201391. https:\/\/doi.org\/10.1007\/s40615-021-01059-8.","journal-title":"J Racial Ethn Health Disparities"},{"key":"3569_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-024-03008-z","author":"M Orellana","year":"2024","unstructured":"Orellana M, DSouza KN, Yap JQ, et al. \u201cIn our community, we normalize pain\u201d: discussions around menstruation and uterine fibroids with Black women and Latinas. BMC Womens Health. 2024. https:\/\/doi.org\/10.1186\/s12905-024-03008-z..","journal-title":"BMC Womens Health"},{"key":"3569_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.10.048","author":"G Levy","year":"2013","unstructured":"Levy G, Hill MJ, Plowden TC, Catherino WH, Armstrong AY. Biomarkers in uterine leiomyoma. Fertil Steril. 2013. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.10.048.","journal-title":"Fertil Steril"},{"key":"3569_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2024.08.037","author":"J Goad","year":"2025","unstructured":"Goad J, Rajkovic A. Uterine fibroids at single-cell resolution: unveiling cellular heterogeneity to improve understanding of pathogenesis and guide future therapies. Am J Obstet Gynecol. 2025. https:\/\/doi.org\/10.1016\/j.ajog.2024.08.037.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"3569_CR10","doi-asserted-by":"publisher","first-page":"75.e1","DOI":"10.1016\/j.ajog.2020.03.018","volume":"223","author":"AP Tran","year":"2020","unstructured":"Tran AP, Al Naber J, Tambor ES, Myers ER. Addressing heterogenous outcomes in uterine fibroid research: a call to action. Am J Obstet Gynecol. 2020;223(1):75.e1-75.e5. https:\/\/doi.org\/10.1016\/j.ajog.2020.03.018.","journal-title":"Am J Obstet Gynecol"},{"key":"3569_CR11","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00010.2024","author":"SE Bulun","year":"2025","unstructured":"Bulun SE, Yin P, Wei JJ, et al. Uterine fibroids. Physiol Rev. 2025. https:\/\/doi.org\/10.1152\/physrev.00010.2024.","journal-title":"Physiol Rev"},{"key":"3569_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10225335","author":"OS Madueke-Laveaux","year":"2021","unstructured":"Madueke-Laveaux OS, Elsharoud A, Al-Hendy A. What we know about the long-term risks of hysterectomy for benign indication\u2014a systematic review. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10225335.","journal-title":"J Clin Med"},{"issue":"3","key":"3569_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00404-025-07932-9","volume":"311","author":"MJ S\u00e1nchez Mart\u00edn","year":"2025","unstructured":"S\u00e1nchez Mart\u00edn MJ, Huerga L\u00f3pez C, Crist\u00f3bal Garc\u00eda I, Crist\u00f3bal Quevedo I. Efficacy of GnRH antagonists in the treatment of uterine fibroids: a meta-analysis. Arch Gynecol Obstet. 2025;311(3):685\u201396. https:\/\/doi.org\/10.1007\/s00404-025-07932-9.","journal-title":"Arch Gynecol Obstet"},{"key":"3569_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dead194","author":"EE Don","year":"2023","unstructured":"Don EE, Mijatovic V, Huirne JAF. Infertility in patients with uterine fibroids: a debate about the hypothetical mechanisms. Hum Reprod. 2023. https:\/\/doi.org\/10.1093\/humrep\/dead194.","journal-title":"Hum Reprod"},{"issue":"5","key":"3569_CR15","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s43441-023-00525-1","volume":"57","author":"O Babalola","year":"2023","unstructured":"Babalola O, Gebben D, Tarver ME, Sangha R, Roberts J, Price V. Patient preferences regarding surgical treatment methods for symptomatic uterine fibroids. Ther Innov Regul Sci. 2023;57(5):976\u201386. https:\/\/doi.org\/10.1007\/s43441-023-00525-1.","journal-title":"Ther Innov Regul Sci"},{"key":"3569_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.315","author":"C Chen","year":"2023","unstructured":"Chen C, Wang J, Pan D, et al. Applications of multi-omics analysis in human diseases. MedComm. 2023. https:\/\/doi.org\/10.1002\/mco2.315.","journal-title":"MedComm"},{"key":"3569_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-027-0_26","author":"ZZ Hu","year":"2011","unstructured":"Hu ZZ, Huang H, Wu CH, et al. Omics-based molecular target and biomarker identification. Methods Mol Biol. 2011. https:\/\/doi.org\/10.1007\/978-1-61779-027-0_26.","journal-title":"Methods Mol Biol"},{"key":"3569_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1045395","author":"L Cai","year":"2022","unstructured":"Cai L, Liao Z, Li S, et al. PLP1 may serve as a potential diagnostic biomarker of uterine fibroids. Front Genet. 2022. https:\/\/doi.org\/10.3389\/fgene.2022.1045395.","journal-title":"Front Genet"},{"issue":"1\u20132","key":"3569_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000513045","volume":"86","author":"M Jacob","year":"2021","unstructured":"Jacob M, Richter R, Sehouli J, David M. Evaluation of biomarkers in myoma patients: a prospective study investigating the role of LDH, CA 125, and IGF-1 after uterus-preserving surgical therapy. Gynecol Obstet Invest. 2021;86(1\u20132):100\u20137. https:\/\/doi.org\/10.1159\/000513045.","journal-title":"Gynecol Obstet Invest"},{"key":"3569_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1153537","author":"L Cai","year":"2023","unstructured":"Cai L, Li J, Long R, et al. An autophagy-related diagnostic biomarker for uterine fibroids: FOS. Front Med. 2023. https:\/\/doi.org\/10.3389\/fmed.2023.1153537.","journal-title":"Front Med"},{"issue":"2","key":"3569_CR21","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1210\/en.2017-03018","volume":"159","author":"MFB Jamaluddin","year":"2018","unstructured":"Jamaluddin MFB, Ko YA, Kumar M, et al. Proteomic profiling of human uterine fibroids reveals upregulation of the extracellular matrix protein periostin. Endocrinology. 2018;159(2):1106\u201318. https:\/\/doi.org\/10.1210\/en.2017-03018.","journal-title":"Endocrinology"},{"key":"3569_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cells14030156","author":"S Boldu-Fern\u00e1ndez","year":"2025","unstructured":"Boldu-Fern\u00e1ndez S, Lliberos C, Simon C, Mas A. Mapping human uterine disorders through single-cell transcriptomics. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14030156.","journal-title":"Cells"},{"key":"3569_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1520436","author":"J Song","year":"2025","unstructured":"Song J, Wang C, Zhao T, et al. Multi-omics approaches for biomarker discovery and precision diagnosis of prediabetes. Front Endocrinol. 2025. https:\/\/doi.org\/10.3389\/fendo.2025.1520436.","journal-title":"Front Endocrinol"},{"key":"3569_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-023-01297-7","author":"I Amendola","year":"2024","unstructured":"Amendola I, Spann M, Segars J, Singh B. The mediator complex subunit 12 (MED-12) gene and uterine fibroids: a systematic review. Reprod Sci. 2024. https:\/\/doi.org\/10.1007\/s43032-023-01297-7.","journal-title":"Reprod Sci"},{"key":"3569_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160","author":"MJ Page","year":"2020","unstructured":"Page MJ, Moher D, Bossuyt PM, et al. PRISMA explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. The BMJ. 2020. https:\/\/doi.org\/10.1136\/bmj.n160.","journal-title":"The BMJ"},{"issue":"16\u201317","key":"3569_CR26","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.clinbiochem.2008.06.018","volume":"41","author":"B Lumbreras","year":"2008","unstructured":"Lumbreras B, Porta M, M\u00e1rquez S, Poll\u00e1n M, Parker LA, Hern\u00e1ndez-Aguado I. QUADOMICS: an adaptation of the quality assessment of diagnostic accuracy assessment (QUADAS) for the evaluation of the methodological quality of studies on the diagnostic accuracy of \u2018-omics\u2019-based technologies. Clin Biochem. 2008;41(16\u201317):1316\u201325. https:\/\/doi.org\/10.1016\/j.clinbiochem.2008.06.018.","journal-title":"Clin Biochem"},{"key":"3569_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57483-5","author":"J Kim","year":"2025","unstructured":"Kim J, Williams A, Noh H, et al. Genome-wide meta-analysis identifies novel risk loci for uterine fibroids within and across multiple ancestry groups. Nat Commun. 2025. https:\/\/doi.org\/10.1038\/s41467-025-57483-5.","journal-title":"Nat Commun"},{"key":"3569_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00511","author":"TL Edwards","year":"2019","unstructured":"Edwards TL, Giri A, Hellwege JN, et al. A trans-ethnic genome-wide association study of uterine fibroids. Front Genet. 2019. https:\/\/doi.org\/10.3389\/fgene.2019.00511.","journal-title":"Front Genet"},{"issue":"3","key":"3569_CR29","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.ajhg.2023.01.009","volume":"110","author":"N V\u00e4lim\u00e4ki","year":"2023","unstructured":"V\u00e4lim\u00e4ki N, Jokinen V, Cajuso T, et al. Inherited mutations affecting the SRCAP complex are central in moderate-penetrance predisposition to uterine leiomyomas. Am J Hum Genet. 2023;110(3):460\u201374. https:\/\/doi.org\/10.1016\/j.ajhg.2023.01.009.","journal-title":"Am J Hum Genet"},{"key":"3569_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25792-z","author":"B Liu","year":"2018","unstructured":"Liu B, Wang T, Jiang J, et al. Association of BET1L and TNRC6B with uterine leiomyoma risk and its relevant clinical features in Han Chinese population. Sci Rep. 2018. https:\/\/doi.org\/10.1038\/s41598-018-25792-z.","journal-title":"Sci Rep"},{"key":"3569_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.512940","author":"I Ponomarenko","year":"2021","unstructured":"Ponomarenko I, Reshetnikov E, Polonikov A, et al. Candidate genes for age at menarche are associated with uterine leiomyoma. Front Genet. 2021. https:\/\/doi.org\/10.3389\/fgene.2020.512940.","journal-title":"Front Genet"},{"key":"3569_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.04.037","author":"LA Wise","year":"2014","unstructured":"Wise LA, Ruiz-Narv\u00e1ez EA, Haddad SA, Rosenberg L, Palmer JR. Polymorphisms in vitamin\u00a0D-related genes and risk of uterine leiomyomata. Fertil Steril. 2014. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.04.037.","journal-title":"Fertil Steril"},{"issue":"3","key":"3569_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/jclinpath-2016-203976","volume":"70","author":"LK Dzhemlikhanova","year":"2017","unstructured":"Dzhemlikhanova LK, Efimova OA, Osinovskaya NS, et al. Catechol-O-methyltransferase Val158Met polymorphism is associated with increased risk of multiple uterine leiomyomas either positive or negative for MED12 exon 2 mutations. J Clin Pathol. 2017;70(3):233\u20136. https:\/\/doi.org\/10.1136\/jclinpath-2016-203976.","journal-title":"J Clin Pathol"},{"issue":"4","key":"3569_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/DMA-2009-0625","volume":"26","author":"S Govindan","year":"2009","unstructured":"Govindan S, Shaik NA, Vedicherla B, Kodati V, Rao KP, Hasan Q. Estrogen receptor-\u03b1 gene (T\/C) Pvu II polymorphism in endometriosis and uterine fibroids. Dis Markers. 2009;26(4):149\u201354. https:\/\/doi.org\/10.3233\/DMA-2009-0625.","journal-title":"Dis Markers"},{"issue":"3","key":"3569_CR35","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1600-0412.2004.00422.x","volume":"83","author":"F Amant","year":"2004","unstructured":"Amant F, Dorfling CM, De Brabanter J, et al. A possible role of the cytochrome P450c17\u03b1 gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot study. Acta Obstet Gynecol Scand. 2004;83(3):234\u20139. https:\/\/doi.org\/10.1111\/j.1600-0412.2004.00422.x.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3569_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/S1658-3876(09)50040-4","author":"N Shaik Ahmad","year":"2009","unstructured":"Shaik Ahmad N, Govindan S, Kodati V, Prabhakar Rao K, Hasan Q. Polymorphic (CAG)n repeats in the androgen receptor gene: a risk marker for endometriosis and uterine leiomyomas. Hematol Oncol Stem Cell Ther. 2009. https:\/\/doi.org\/10.1016\/S1658-3876(09)50040-4.","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"5","key":"3569_CR37","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/ng.805","volume":"43","author":"PC Cha","year":"2011","unstructured":"Cha PC, Takahashi A, Hosono N, et al. A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids. Nat Genet. 2011;43(5):447\u201351. https:\/\/doi.org\/10.1038\/ng.805.","journal-title":"Nat Genet"},{"key":"3569_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05428-6","author":"T Rafnar","year":"2018","unstructured":"Rafnar T, Gunnarsson B, Stefansson OA, et al. Variants associating with uterine leiomyoma highlight genetic background shared by various cancers and hormone-related traits. Nat Commun. 2018. https:\/\/doi.org\/10.1038\/s41467-018-05428-6.","journal-title":"Nat Commun"},{"key":"3569_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.genrep.2025.102417","volume":"1","author":"AM Elsaid","year":"2026","unstructured":"Elsaid AM, Elsayed YM, Abu Almaaty AH, Eid MI, Hasan AK. Cycloxygenase-2 (\u2212765G>C) gene polymorphism and risk of uterine fibroids in Egyptian women. Gene Rep. 2026;1:42. https:\/\/doi.org\/10.1016\/j.genrep.2025.102417.","journal-title":"Gene Rep"},{"issue":"10","key":"3569_CR40","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00439-017-1836-1","volume":"136","author":"JN Hellwege","year":"2017","unstructured":"Hellwege JN, Jeff JM, Wise LA, et al. A multi-stage genome-wide association study of uterine fibroids in African Americans. Hum Genet. 2017;136(10):1363\u201373. https:\/\/doi.org\/10.1007\/s00439-017-1836-1.","journal-title":"Hum Genet"},{"issue":"1","key":"3569_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1262\/jrd.2013-095","volume":"60","author":"S Sato","year":"2014","unstructured":"Sato S, Maekawa R, Yamagata Y, Asada H, Tamura I, Lee L, et al. Potential Mechanisms of Aberrant DNA Hypomethylation on the X Chromosome in Uterine Leiomyomas. J Reprod Dev. 2014;60(1):31\u20136. https:\/\/doi.org\/10.1262\/jrd.2013-095.","journal-title":"J Reprod Dev."},{"key":"3569_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/srep30652","volume":"6","author":"S Sato","year":"2016","unstructured":"Sato S, Maekawa R, Yamagata Y, et al. Identification of uterine leiomyoma-specific marker genes based on DNA methylation and their clinical application. Sci Rep. 2016;6:6. https:\/\/doi.org\/10.1038\/srep30652.","journal-title":"Sci Rep"},{"key":"3569_CR43","doi-asserted-by":"publisher","DOI":"10.1262\/jrd.11-035a","author":"R Maekawa","year":"2011","unstructured":"Maekawa R, Yagi S, Ohgane J, et al. Disease-dependent differently methylated regions (D-DMRs) of DNA are enriched on the X chromosome in uterine leiomyoma. J Reprod Dev. 2011. https:\/\/doi.org\/10.1262\/jrd.11-035a.","journal-title":"J Reprod Dev"},{"key":"3569_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109784","volume":"76","author":"W Wang","year":"2020","unstructured":"Wang W, Zhou L, Wang J, Zhang X, Liu G. Circular RNA expression profiling identifies novel biomarkers in uterine leiomyoma. Cell Signal. 2020;76:76. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109784.","journal-title":"Cell Signal"},{"key":"3569_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23114","author":"E Fazeli","year":"2020","unstructured":"Fazeli E, Piltan S, Sadeghi H, et al. Ectopic expression of CYP24A1 circular RNA hsa_circ_0060927 in uterine leiomyomas. J Clin Lab Anal. 2020. https:\/\/doi.org\/10.1002\/jcla.23114.","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"3569_CR46","first-page":"106","volume":"30","author":"KV Litovkin","year":"2008","unstructured":"Litovkin KV, Ivanova OV, Bauer A, Hoheisel JD, Bubnov VV, Zaporozhan VN. Microarray study of gene expression in uterine leiomyoma. Exp Oncol. 2008;30(2):106\u201311.","journal-title":"Exp Oncol"},{"key":"3569_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.856745","author":"X Peng","year":"2022","unstructured":"Peng X, Mo Y, Liu J, Liu H, Wang S. Identification and validation of miRNA-TF-mRNA regulatory networks in uterine fibroids. Front Bioeng Biotechnol. 2022. https:\/\/doi.org\/10.3389\/fbioe.2022.856745.","journal-title":"Front Bioeng Biotechnol"},{"issue":"5","key":"3569_CR48","doi-asserted-by":"publisher","first-page":"6985","DOI":"10.3892\/mmr.2018.8756","volume":"17","author":"Y Liu","year":"2018","unstructured":"Liu Y, Liu X, Liu Y, Zhao J. Screening of potential biomarkers in uterine leiomyomas disease via gene expression profiling analysis. Mol Med Rep. 2018;17(5):6985\u201396. https:\/\/doi.org\/10.3892\/mmr.2018.8756.","journal-title":"Mol Med Rep"},{"key":"3569_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/S12885-019-5775-1","author":"E Yang","year":"2019","unstructured":"Yang E, Xue L, Li Z, Yi T. Lnc-AL445665.1\u20134 may be involved in the development of multiple uterine leiomyoma through interacting with miR-146b-5p. BMC Cancer. 2019. https:\/\/doi.org\/10.1186\/S12885-019-5775-1.","journal-title":"BMC Cancer"},{"key":"3569_CR50","doi-asserted-by":"publisher","unstructured":"Guo H, Zhang X, Dong R, et al. Integrated analysis of long noncoding RNAs and mRNAs reveals their potential roles in the pathogenesis of uterine leiomyomas. Oncotarget. 2014;5(18):8625\u201336. https:\/\/doi.org\/10.18632\/oncotarget.2349.","DOI":"10.18632\/oncotarget.2349"},{"issue":"12","key":"3569_CR51","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.1210\/jc.2019-00762","volume":"104","author":"I Okeigwe","year":"2019","unstructured":"Okeigwe I, Bulun S, Liu S, et al. PLIN2 functions as a novel link between progesterone signaling and metabolism in uterine leiomyoma cells. J Clin Endocrinol Metab. 2019;104(12):6256\u201364. https:\/\/doi.org\/10.1210\/jc.2019-00762.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3569_CR52","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/1933719117711265","volume":"25","author":"TD Chuang","year":"2018","unstructured":"Chuang TD, Khorram O. Expression profiling of lncRNAs, miRNAs, and mRNAs and their differential expression in leiomyoma using next-generation RNA sequencing. Reprod Sci. 2018;25(2):246\u201355. https:\/\/doi.org\/10.1177\/1933719117711265.","journal-title":"Reprod Sci"},{"issue":"1","key":"3569_CR53","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.fertnstert.2020.07.024","volume":"115","author":"TD Chuang","year":"2021","unstructured":"Chuang TD, Rehan A, Khorram O. Functional role of the long noncoding RNA X-inactive specific transcript in leiomyoma pathogenesis. Fertil Steril. 2021;115(1):238\u201347. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.07.024.","journal-title":"Fertil Steril"},{"issue":"5","key":"3569_CR54","doi-asserted-by":"publisher","first-page":"8005","DOI":"10.3892\/ol.2018.8325","volume":"15","author":"B Ura","year":"2018","unstructured":"Ura B, Scrimin F, Arrigoni G, Aloisio M, Monasta L, Ricci G. Dysregulated chaperones associated with cell proliferation and negative apoptosis regulation in the uterine leiomyoma. Oncol Lett. 2018;15(5):8005\u201310. https:\/\/doi.org\/10.3892\/ol.2018.8325.","journal-title":"Oncol Lett"},{"key":"3569_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mcp.2017.07.001","volume":"36","author":"Y Liu","year":"2017","unstructured":"Liu Y, Lu D, Sheng J, Luo L, Zhang W. Identification of TRADD as a potential biomarker in human uterine leiomyoma through iTRAQ based proteomic profiling. Mol Cell Probes. 2017;36:15\u201320. https:\/\/doi.org\/10.1016\/j.mcp.2017.07.001.","journal-title":"Mol Cell Probes"},{"key":"3569_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-021-00580-9","author":"T Sahar","year":"2021","unstructured":"Sahar T, Nigam A, Anjum S, Gupta N, Wajid S. Secretome profiling and computational biology of human leiomyoma samples unravel molecular signatures with potential for diagnostic and therapeutic interventions. Reprod Sci. 2021. https:\/\/doi.org\/10.1007\/s43032-021-00580-9.","journal-title":"Reprod Sci"},{"issue":"4","key":"3569_CR57","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1039\/c2mb05453a","volume":"8","author":"CP Lin","year":"2012","unstructured":"Lin CP, Chen YW, Liu WH, et al. Proteomic identification of plasma biomarkers in uterine leiomyoma. Mol Biosyst. 2012;8(4):1136\u201345. https:\/\/doi.org\/10.1039\/c2mb05453a.","journal-title":"Mol Biosyst"},{"key":"3569_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89859-0","author":"NM Tonoyan","year":"2021","unstructured":"Tonoyan NM, Chagovets VV, Starodubtseva NL, et al. Alterations in lipid profile upon uterine fibroids and its recurrence. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/s41598-021-89859-0.","journal-title":"Sci Rep"},{"issue":"12","key":"3569_CR59","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1038\/bjc.2017.361","volume":"117","author":"HR Heinonen","year":"2017","unstructured":"Heinonen HR, Mehine M, M\u00e4kinen N, et al. Global metabolomic profiling of uterine leiomyomas. Br J Cancer. 2017;117(12):1855\u201364. https:\/\/doi.org\/10.1038\/bjc.2017.361.","journal-title":"Br J Cancer"},{"key":"3569_CR60","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac061","author":"GAS Barison","year":"2022","unstructured":"Barison GAS, D\u2019amora P, Izidoro MA, et al. Metabolomic profiling of peripheral plasma by GC-MS and correlation with size of uterine leiomyomas. J Endocr Soc. 2022. https:\/\/doi.org\/10.1210\/jendso\/bvac061.","journal-title":"J Endocr Soc"},{"key":"3569_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1373011","author":"Y Li","year":"2024","unstructured":"Li Y, Chen H, Zhang H, Lin Z, Song L, Zhao C. Identification of oxidative stress-related biomarkers in uterine leiomyoma: a transcriptome-combined Mendelian randomization analysis. Front Endocrinol (Lausanne). 2024. https:\/\/doi.org\/10.3389\/fendo.2024.1373011.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"3569_CR62","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1073\/pnas.1518752113","volume":"113","author":"M Mehine","year":"2016","unstructured":"Mehine M, Kaasinen E, Heinonen HR, et al. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc Natl Acad Sci U S A. 2016;113(5):1315\u201320. https:\/\/doi.org\/10.1073\/pnas.1518752113.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3569_CR63","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jbi.2015.08.014","volume":"57","author":"S Mallik","year":"2015","unstructured":"Mallik S, Maulik U. MiRNA-TF-gene network analysis through ranking of biomolecules for multi-informative uterine leiomyoma dataset. J Biomed Inform. 2015;57:308\u201319. https:\/\/doi.org\/10.1016\/j.jbi.2015.08.014.","journal-title":"J Biomed Inform"},{"key":"3569_CR64","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.37110","author":"N V\u00e4likm\u00e4ki","year":"2018","unstructured":"V\u00e4likm\u00e4ki N, Kuisma H, Pasanen A, Heikinheimo O, Sj\u00f6berg J. Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability. Elife. 2018. https:\/\/doi.org\/10.7554\/eLife.37110.","journal-title":"Elife"},{"key":"3569_CR65","unstructured":"Obeagu EI, Obeagu GU. Unraveling the role of transforming growth factor-beta (TGF-\u03b2) in the progression of fibroids. Elite J Med. 2024;2(2):67\u201377."},{"key":"3569_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-023-09521-z","author":"T Sun","year":"2023","unstructured":"Sun T, Xiao C, Yang Z, Deng J, Yang X. Transcriptome profiling analysis of uterus during chicken laying periods. BMC Genomics. 2023. https:\/\/doi.org\/10.1186\/s12864-023-09521-z.","journal-title":"BMC Genomics"},{"key":"3569_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.475","author":"MS Islam","year":"2021","unstructured":"Islam MS, Afrin S, Singh B, et al. Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids. Clin Transl Med. 2021. https:\/\/doi.org\/10.1002\/ctm2.475.","journal-title":"Clin Transl Med"},{"key":"3569_CR68","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100354R","author":"Y Yan","year":"2021","unstructured":"Yan Y, Liu J, Lawrence A, et al. Prolonged cadmium exposure alters benign uterine fibroid cell behavior, extracellular matrix components, and TGFB signaling. FASEB J. 2021. https:\/\/doi.org\/10.1096\/fj.202100354R.","journal-title":"FASEB J"},{"key":"3569_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2023.10.002","author":"EE Saad","year":"2024","unstructured":"Saad EE, Michel R, Borahay MA. Immunosuppressive tumor microenvironment and uterine fibroids: role in collagen synthesis. Cytokine Growth Factor Rev. 2024. https:\/\/doi.org\/10.1016\/j.cytogfr.2023.10.002.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3569_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/cells12081117","author":"M Ali","year":"2023","unstructured":"Ali M, Ciebiera M, Vafaei S, et al. Progesterone signaling and uterine fibroid pathogenesis; molecular mechanisms and potential therapeutics. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12081117.","journal-title":"Cells"},{"issue":"9","key":"3569_CR71","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1177\/1933719116678686","volume":"24","author":"MA Borahay","year":"2017","unstructured":"Borahay MA, Asoglu MR, Mas A, Adam S, Kilic GS, Al-Hendy A. Estrogen receptors and signaling in fibroids: role in pathobiology and therapeutic implications. Reprod Sci. 2017;24(9):1235\u201344.","journal-title":"Reprod Sci"},{"key":"3569_CR72","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1374821","author":"T Rabe","year":"2018","unstructured":"Rabe T, Saenger N, Ebert AD, et al. Selective progesterone receptor modulators for the medical treatment of uterine fibroids with a focus on ulipristal acetate. BioMed Res Int. 2018. https:\/\/doi.org\/10.1155\/2018\/1374821.","journal-title":"BioMed Res Int"},{"key":"3569_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53467-w","author":"HB Nair","year":"2019","unstructured":"Nair HB, Santhamma B, Dileep KV, et al. EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fibroids in a human uterine fibroid tissue xenograft model. Sci Rep. 2019. https:\/\/doi.org\/10.1038\/s41598-019-53467-w.","journal-title":"Sci Rep"},{"issue":"7","key":"3569_CR74","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1056\/nejmoa2008283","volume":"384","author":"A Al-Hendy","year":"2021","unstructured":"Al-Hendy A, Lukes AS, Poindexter AN, et al. Treatment of uterine fibroid symptoms with relugolix combination therapy. N Engl J Med. 2021;384(7):630\u201342. https:\/\/doi.org\/10.1056\/nejmoa2008283.","journal-title":"N Engl J Med"},{"key":"3569_CR75","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3914232","volume":"2019","author":"MJ B\u00f6hm","year":"2019","unstructured":"B\u00f6hm MJ, Marienfeld R, J\u00e4ger D, et al. Analysis of the CDK4\/6 cell cycle pathway in leiomyosarcomas as a potential target for inhibition by palbociclib. Sarcoma. 2019;2019:3914232. https:\/\/doi.org\/10.1155\/2019\/3914232.","journal-title":"Sarcoma"},{"issue":"9","key":"3569_CR76","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1158\/1535-7163.MCT-17-0040","volume":"16","author":"AM Francis","year":"2017","unstructured":"Francis AM, Alexander A, Liu Y, et al. CDK4\/6 inhibitors sensitize Rb-positive sarcoma cells to Wee1 kinase inhibition through reversible cell-cycle arrest. Mol Cancer Ther. 2017;16(9):1751\u201364. https:\/\/doi.org\/10.1158\/1535-7163.MCT-17-0040.","journal-title":"Mol Cancer Ther"},{"key":"3569_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01661-8","author":"J Martin-Broto","year":"2023","unstructured":"Martin-Broto J, Martinez-Garcia J, Moura DS, et al. Phase\u00a0II trial of CDK4\/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4\/ CDKN2A. Signal Transduct Target Ther. 2023. https:\/\/doi.org\/10.1038\/s41392-023-01661-8.","journal-title":"Signal Transduct Target Ther"},{"key":"3569_CR78","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S54565","author":"N Biglia","year":"2014","unstructured":"Biglia N, Carinelli S, Maiorana A, D\u2019Alonzo M, Lo MG, Marci R. Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids. Drug Design Dev Ther. 2014. https:\/\/doi.org\/10.2147\/DDDT.S54565.","journal-title":"Drug Design Dev Ther"},{"key":"3569_CR79","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/436174","volume":"2012","author":"P Horak","year":"2012","unstructured":"Horak P, Mara M, Dundr P, et al. Effect of a selective progesterone receptor modulator on induction of apoptosis in uterine fibroids in vivo. Int J Endocrinol. 2012;2012:436174. https:\/\/doi.org\/10.1155\/2012\/436174.","journal-title":"Int J Endocrinol"},{"issue":"5","key":"3569_CR80","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.fertnstert.2009.08.065","volume":"94","author":"D Zhang","year":"2010","unstructured":"Zhang D, Al-Hendy M, Richard-Davis G, Montgomery-Rice V, Rajaratnam V, Al-Hendy A. Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells. Fertil Steril. 2010;94(5):1887\u201393. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.08.065.","journal-title":"Fertil Steril"},{"key":"3569_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64871-y","author":"JW Lee","year":"2020","unstructured":"Lee JW, Choi HJ, Kim EJ, Hwang WY, Jung MH, Kim KS. Fisetin induces apoptosis in uterine leiomyomas through multiple pathways. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-64871-y.","journal-title":"Sci Rep"},{"key":"3569_CR82","doi-asserted-by":"publisher","unstructured":"Islam S, Giampieri F, Janjusevic M, et al. An anthocyanin rich strawberry extract induces apoptosis and ROS while decreases glycolysis and fibrosis in human uterine leiomyoma cells. Oncotarget. 2017;8(14):23575\u201387. https:\/\/doi.org\/10.18632\/oncotarget.15333","DOI":"10.18632\/oncotarget.15333"},{"key":"3569_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12040807","author":"A AlAshqar","year":"2023","unstructured":"AlAshqar A, Lulseged B, Mason-Otey A, et al. Oxidative stress and antioxidants in uterine fibroids: pathophysiology and clinical implications. Antioxidants Basel. 2023. https:\/\/doi.org\/10.3390\/antiox12040807.","journal-title":"Antioxidants Basel"},{"key":"3569_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.70231","author":"I Ploumaki","year":"2025","unstructured":"Ploumaki I, El Sayed S, Asamoah-Mensah A, Macri VI, Segars JH, Islam MS. The potential of vitamin\u00a0D and epigallocatechin gallate (EGCG) for the treatment of uterine fibroids: evidence from in vitro to clinical studies. Mol Nutr Food Res. 2025. https:\/\/doi.org\/10.1002\/mnfr.70231.","journal-title":"Mol Nutr Food Res"},{"issue":"3s","key":"3569_CR85","doi-asserted-by":"publisher","first-page":"857","DOI":"10.53555\/AJBR.v28i3S.7761","volume":"28","author":"O Moyosola Olumide","year":"2025","unstructured":"Moyosola Olumide O, Olatunji-Bello I, Morounke Saibu G, et al. Vitamin\u00a0D modulator of oxidative stress, pro-inflammatory cytokines and hormonal disruptions in monosodium glutamate (MSG)-induced uterine leiomyoma in wistar rat models. Afr J Biomed Res. 2025;28(3s):857\u201365. https:\/\/doi.org\/10.53555\/AJBR.v28i3S.7761.","journal-title":"Afr J Biomed Res"},{"issue":"9","key":"3569_CR86","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1177\/1933719114532839","volume":"21","author":"G Suo","year":"2014","unstructured":"Suo G, Sadarangani A, Tang W, Cowan BD, Wang JYJ. Telomerase expression abrogates rapamycin-induced irreversible growth arrest of uterine fibroid smooth muscle cells. Reprod Sci. 2014;21(9):1161\u201370. https:\/\/doi.org\/10.1177\/1933719114532839.","journal-title":"Reprod Sci"},{"key":"3569_CR87","doi-asserted-by":"publisher","DOI":"10.1530\/REP-21-0087","author":"GW Kirschen","year":"2021","unstructured":"Kirschen GW, AlAshqar A, Miyashita-Ishiwata M, Reschke L, El Sabeh M, Borahay MA. Vascular biology of uterine fibroids: connecting fibroids and vascular disorders. Reproduction. 2021. https:\/\/doi.org\/10.1530\/REP-21-0087.","journal-title":"Reproduction"},{"key":"3569_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-12954-z","author":"S Han","year":"2025","unstructured":"Han S, Choi EK, Ahn HJ, et al. Increased risk of atrial fibrillation in uterine fibroid patients: a nationwide population-based study. Sci Rep. 2025. https:\/\/doi.org\/10.1038\/s41598-025-12954-z.","journal-title":"Sci Rep"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03569-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03569-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03569-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:51:42Z","timestamp":1780116702000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03569-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["3569"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03569-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors (Fatimah Hussein, Ola Elamin, Ayman Al-Hendy, and Mira Mousa) declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}